These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8607109)

  • 1. Semi-automated detection of the factor V mutation by allele specific amplification and capillary electrophoresis.
    van de Locht LT; Kuypers AW; Verbruggen BW; Linssen PC; Nováková IR; Mensink EJ
    Thromb Haemost; 1995 Nov; 74(5):1276-9. PubMed ID: 8607109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simple and rapid detection of factor V Leiden by allele-specific PCR amplification.
    Blasczyk R; Ritter M; Thiede C; Wehling J; Hintz G; Neubauer A; Riess H
    Thromb Haemost; 1996 May; 75(5):757-9. PubMed ID: 8725719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid genotyping of factor V Leiden mutation using single-tube bidirectional allele-specific amplification and automated ultrathin-layer agarose gel electrophoresis.
    Sasvari-Szekely M; Gerstner A; Ronai Z; Staub M; Guttman A
    Electrophoresis; 2000 Mar; 21(4):816-21. PubMed ID: 10733227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The polymerase chain reaction with sequence specific primers for the detection of the factor V mutation associated with activated protein C resistance.
    Kirschbaum NE; Foster PA
    Thromb Haemost; 1995 Sep; 74(3):874-8. PubMed ID: 8571314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism.
    Blasczyk R; Wehling J; Ritter M; Neubauer A; Riess H
    Beitr Infusionsther Transfusionsmed; 1997; 34():236-41. PubMed ID: 9356679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation in the gene coding for coagulation factor V and resistance to activated protein C: detection of the genetic mutation by oligonucleotide ligation assay using a semi-automated system.
    Zotz RB; Maruhn-Debowski B; Scharf RE
    Thromb Haemost; 1996 Jul; 76(1):53-5. PubMed ID: 8819251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allelic discrimination of factor V Leiden using a 5' nuclease assay.
    Happich D; Schwaab R; Hanfland P; Hoernschemeyer D
    Thromb Haemost; 1999 Oct; 82(4):1294-6. PubMed ID: 10544916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple and reliable factor V genotyping by PNA-mediated PCR clamping.
    Behn M; Schuermann M
    Thromb Haemost; 1998 Apr; 79(4):773-7. PubMed ID: 9569191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hemi-nested, allele specific, whole blood PCR assay for the detection of the factor V Leiden mutation.
    Sinclair GD; Low S; Poon MC
    Thromb Haemost; 1997 Jun; 77(6):1154-5. PubMed ID: 9241749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor V Leiden mutation which predisposes to thrombosis is not common in patients with antiphospholipid syndrome.
    Dizon-Townson D; Hutchison C; Silver R; Branch DW; Ward K
    Thromb Haemost; 1995 Oct; 74(4):1029-31. PubMed ID: 8560406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenotyping and genotyping of coagulation factor V Leiden.
    Engel H; Zwang L; van Vliet HH; Michiels JJ; Stibbe J; Lindemans J
    Thromb Haemost; 1996 Feb; 75(2):267-9. PubMed ID: 8815574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ARMS test for diagnosis of factor V Leiden mutation and allele frequencies in France.
    Bathelier C; Champenois T; Lucotte G
    Mol Cell Probes; 1998 Apr; 12(2):121-3. PubMed ID: 9633048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor V Leiden genotyping using real-time fluorescent polymerase chain reaction.
    Sanders Sevall J
    Mol Cell Probes; 2000 Aug; 14(4):249-53. PubMed ID: 10970729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid multiplex analysis for the factor V Leiden and prothrombin G20210A mutations associated with hereditary thrombophilia.
    Linfert DR; Rezuke WN; Tsongalis GJ
    Conn Med; 1998 Sep; 62(9):519-25. PubMed ID: 9785636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ARMS test for diagnosis of factor VLeiden mutation, a common cause of inherited thrombotic tendency.
    Yandava CN; Zappulla DC; Korf BR; Neufeld EJ
    J Clin Lab Anal; 1996; 10(6):414-7. PubMed ID: 8951612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR.
    Mitterer M; Lanthaler AJ; Mair W; Giacomuzzi K; Coser P
    Haematologica; 1999 Mar; 84(3):204-7. PubMed ID: 10189382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two rare confounding polymorphisms proximal to the factor V Leiden mutation.
    Gold B; Hanson M; Dean M
    Mol Diagn; 2001 Jun; 6(2):137-40. PubMed ID: 11468699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.